The use of dextromethorphan (DXM) in medicine has been around for decades. It is a common ingredient in many over-the-counter (OTC) cough medicines, and is also used to treat certain types of pain. Recently, however, there has been a rise in the use of high-dose DXM for recreational purposes. This has led to an increase in potential health risks, particularly among adolescents and young adults. In this article, we will explore the effects of high-dose DXM and discuss why it is important for doctors to be aware of the potential risks associated with its use.
Dextromethorphan (DXM) is an opioid derivative that is commonly found in OTC cough and cold medicines. It works by blocking the cough reflex, which helps to suppress coughing. DXM is also used to treat certain types of pain, such as neuropathic pain. It is available in both tablet and liquid forms, and is typically taken in doses of 10-30 milligrams (mg) per day.
High-dose DXM is defined as taking more than 30 mg of DXM in a single dose, or taking multiple doses of DXM throughout the day. This type of DXM use is also known as “stacking”, and it is becoming increasingly popular among adolescents and young adults. High-dose DXM is often taken to achieve a “high”, or to experience a sense of euphoria.
There are a number of potential health risks associated with high-dose DXM use. These include an increased risk of liver damage, increased heart rate and blood pressure, and increased risk of seizures. Additionally, high-dose DXM can lead to an increased risk of addiction and dependence.
High-dose DXM use has also been associated with a number of neuropsychiatric effects, such as confusion, disorientation, and hallucinations. These effects can be particularly dangerous, as they can lead to impaired decision-making and an increased risk of self-harm or injury.
High-dose DXM use can also lead to long-term effects, such as memory loss, cognitive impairment, and depression. Additionally, it has been linked to an increased risk of developing certain types of cancers, such as liver and kidney cancer.
Given the potential health risks associated with high-dose DXM use, it is important for doctors to be aware of the dangers associated with this type of drug use. Doctors should be aware of the signs and symptoms of DXM use, and should be prepared to provide appropriate treatment and support to those who are struggling with addiction. Additionally, doctors should be aware of the potential long-term effects of high-dose DXM use, and should be prepared to provide appropriate follow-up care and monitoring.
High-dose DXM use is becoming increasingly popular among adolescents and young adults, and it is associated with a number of potential health risks. It is important for doctors to be aware of the potential dangers associated with this type of drug use, and to be prepared to provide appropriate treatment and support to those who are struggling with addiction. By understanding the effects of high-dose DXM, doctors can help to ensure that their patients are safe and healthy.
1.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
2.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
3.
Aster Whitefield Hospital, with 506 beds, opened.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC
1.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
2.
Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs
3.
Stomach Cancer: Uncovering the Subtle Signs and Symptoms
4.
All You Need to Know About Mesna: The Ultimate Guide
5.
Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation